MUMBAI (Reuters) – Drug maker Cipla Ltd on Wednesday launched its generic version of Roche’s Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.
Cipla’s Oseltamivir brand, called Antiflu, will cost 475 rupees for 10 capsules, with 75 ml syrup will be similarly priced.
Cipla’s drug is also pre-qualified by the World Health Organisation.
(For more news on Reuters Money visit www.reutersmoney.in )
Pingback: Cipla launches drug to treat H1N1 virus « Hyderabad News is the … | H1N1 TREATMENT US
Pingback: Cipla launches drug to treat H1N1 virus « Hyderabad News is the …